News Archives | Lucence

Interim Results from LIQUIK Prospective Study Released at WCLC 2023

Lucence Announces CPT PLA Code Granted to LiquidHALLMARK®

Lucence and Innovent Announce Strategic Collaboration on Bile Duct Cancer

Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2023 ASCO Annual Meeting

Lucence Launches LucenceINSIGHT to Detect Cancer Earlier

Lucence secures US Medicare approval for its cancer tests

Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK® Assay in Lung Cancer

Lucence Shares Promising Interim Data from LIQUIK Prospective Study at ISLB 2022

Lucence and Omnigen Partner to bring Amplicon-based Liquid Biopsy Tests to Turkey

Lucence Collaborates with National Cancer Centre Singapore to Launch Prospective Liquid Biopsy Study for Prostate Cancer

Lucence Showcases Liquid Biopsy Tech for Earlier Cancer Detection at 2023 ASCO

>